RPN2 gene confers docetaxel resistance in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RPN2 gene confers docetaxel resistance in breast cancer

Published:2008-08-17 Issue:9 Volume:14 Page:939-948
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Honma Kimi,Iwao-Koizumi Kyoko,Takeshita Fumitaka,Yamamoto Yusuke,Yoshida Teruhiko,Nishio Kazuto,Nagahara Shunji,Kato Kikuya,Ochiya Takahiro

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.1858.pdf

Reference50 articles.

1. Kaufmann, M. et al. International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations. J. Clin. Oncol. 21, 2600–2608 (2003).

2. Gradishar, W.J. et al. Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer. Ann. Oncol. 16, 1297–1304 (2005).

3. Formenti, S.C. et al. Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: A phase I/II trial. J. Clin. Oncol. 21, 864–870 (2003).

4. Engels, F.K., Sparreboom, A., Mathot, R.A. & Verweij, J. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review. Br. J. Cancer 93, 173–177 (2005).

5. Crown, J., O'Leary, M. & Ooi, W.S. Docetaxel & paclitaxel in the treatment of breast cancer: a review of clinical experience. Oncologist 9, 24–32 (2004).

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide;Molecular Neurobiology;2024-07-18

2. Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution;Cancer Cell;2024-07

3. Metabolism pathway-based subtyping in endometrial cancer: An integrated study by multi-omics analysis and machine learning algorithms;Molecular Therapy - Nucleic Acids;2024-06

4. An emerging role of N-glycosylation in cancer chemoresistance;Carbohydrate Research;2024-05

5. Feature Detection Based on Imaging and Genetic Data Using Multi-Kernel Support Vector Machine–Apriori Model;Mathematics;2024-02-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3